-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation